Evidence map›Paper›PMID 23328664›Full record

ArticleCell death & disease2013

Manumycin A inhibits triple-negative breast cancer growth through LC3-mediated cytoplasmic vacuolation death.

P K Singha, S Pandeswara, M A Venkatachalam, P Saikumar

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

P K SinghaDepartment of Pathology, UT Health Science Center at San Antonio, San Antonio, TX 78229, USA.
S Pandeswara
M A Venkatachalam
P Saikumar
The University of Texas Health Science Center at San Antonio · US

Funding

PTEN REGULATION DURING ISCHEMIC ACUTE RENAL FAILURER01DK037139 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI VENKATACHALAM, MANJERI A · 1987 to 2008
$2.3M
CELL PATHOLOGY IN KIDNEY HYPOXIA. ROLE OF BAXR01DK054472 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SAIKUMAR, POTHANA · 1998 to 2007
$2.0M
MEMBRANE PATHOLOGY IN RENAL CELL INJURYR37DK037139 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VENKATACHALAM, MANJERI A · 1996 to 2003
$1.8M
NIDDK NIH HHS DK37139NIDDK NIH HHS DK54472NIDDK NIH HHS R01 DK037139NIDDK NIH HHS R01 DK054472NIDDK NIH HHS R37 DK037139
6 · The paper itself

Abstract

Therapy resistance can be attributed to acquisition of anti-apoptotic mechanisms by the cancer cells. Therefore, developing approaches that trigger non-apoptotic cell death in cancer cells to compensate for apoptosis resistance will help to treat cancer effectively. Triple-negative breast cancers (TNBC) are among the most aggressive and therapy resistant to breast tumors. Here we report that manumycin A (Man A), an inhibitor of farnesyl protein transferase, reduces cancer cell viability through induction of non-apoptotic, non-autophagic cytoplasmic vacuolation death in TNBC cells. Man A persistently induced cytoplasmic vacuolation and cell death through the expression of microtubule-associated protein 1 light chain 3 (LC3) and p62 proteins along with endoplasmic reticulum (ER) stress markers, Bip and CHOP, and accumulation of ubiquitinated proteins. As inhibitors of apoptosis and autophagy failed to block cytoplasmic vacuolation and its associated protein expression or cell death, it appears that these processes are not involved in the death induced by Man A. Ability of thiol antioxidant, NAC in blocking Man A-induced vacuolation, death and its related protein expression suggests that sulfhydryl homeostasis may be the target of Man A. Surprisingly, normal human mammary epithelial cells failed to undergo cytoplasmic vacuolation and cell death, and grew normally in presence of Man A. In conjunction with its in vitro effects, Man A also reduced tumor burden in vivo in xenograft models that showed extensive cytoplasmic vacuoles and condensed nuclei with remarkable increase in the vacuolation-associated protein expression together with increase of p21, p27, PTEN and decrease of pAkt. Interestingly, Man A-mediated upregulation of p21, p27 and PTEN and downregulation of pAkt and tumor growth suppression were also mimicked by LC3 knockdown in MDA-MB-231 cells. Overall, these results suggest novel therapeutic actions by Man A through the induction of non-apoptotic and non-autophagic cytoplasmic vacuolation death by probably affecting ER stress, LC3 and p62 pathways in TNBC but not in normal mammary epithelial cells.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAnti-Bacterial AgentsApoptosisBreast NeoplasmsCell LineCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27Drug Resistance, NeoplasmEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressEpithelial CellsFarnesyltranstransferaseFemaleHeat-Shock ProteinsHumansAdaptor Proteins, Signal TransducingAnti-Bacterial AgentsCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27DDIT3 protein, humanEndoplasmic Reticulum Chaperone BiPFarnesyltranstransferaseHeat-Shock ProteinsmanumycinMAP1LC3A protein, humanMicrotubule-Associated ProteinsPolyenesPolyunsaturated AlkamidesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanSequestosome-1 ProteinSQSTM1 protein, humanTranscription Factor CHOP

Identifiers

PMID23328664
PMCPMC3563980
OpenAlexW1976856568

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.